Rare presentations can suggest more than one rare condition: Striking personal and family cancer history in a patient with both CDKN2A and BRCA1 pathogenic variants

Rare presentations can suggest more than one rare condition: Striking personal and family cancer history in a patient with both CDKN2A and BRCA1 pathogenic variants

Bibliographic Details
Main Authors:	Nicole Trupiano, BS, Erika Koeppe, MS, Michelle F. Jacobs, MS, Tobias Else, MD, Kelly B. Cha, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	JAAD Case Reports
Subjects:	CDKN2A cancer predisposition cancer screening BRCA1 familial melanoma multiple melanoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622004933

Similar Items

<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer Syndromes
by: Anastasiia Danishevich, et al.
Published: (2023-12-01)

CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
by: Carol Cremin, et al.
Published: (2018-03-01)

Selected Aspects of Molecular Diagnostics of Constitutional Alterations in <it>BRCA1 </it>and <it>BRCA2 </it>Genes Associated with Increased Risk of Breast Cancer in the Polish Population
by: Górski Bohdan
Published: (2006-08-01)

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
by: Kristen Pauley, et al.
Published: (2022-03-01)

Male BRCA mutation carriers: clinical characteristics and cancer spectrum
by: Mohammed Ibrahim, et al.
Published: (2018-02-01)

CD8-Lymphocytic Phenotype Significance in Primary Multiple and Familial Melanoma with Various CDKN2A Mutational Status
by: Luana-Andreea Boşoteanu, et al.
Published: (2023-12-01)

Carrier screening program for BRCA1/BRCA2 pathogenic variants among Ashkenazi Jewish women in Israel: An observational study
by: Rotem Greenberg, et al.
Published: (2023-01-01)

Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
by: Gabriel S. Macedo, et al.
Published: (2019-04-01)

<a name="home"></a>The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma
by: J. Huber, et al.
Published: (2006-02-01)

Vitiligo-like amelanotic melanoma in situ: A rare presentation
by: Lilia Maria Lima de Oliveira, MD, et al.
Published: (2024-05-01)

High frequency of BRCA recurrent mutations in a consecutive series of unselected ovarian cancer patients
by: Chicos Andrei, et al.
Published: (2020-07-01)

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
by: Milena Casula, et al.
Published: (2019-08-01)

CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner
by: Zhen Zhu, et al.
Published: (2021-03-01)

CDKN2A-positive melanoma patient treated with combination immunotherapy – A case report
by: Katarina Zevnik, et al.
Published: (2022-07-01)

Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey
by: Aysel Çakır, et al.
Published: (2023-07-01)

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes
by: Lenka Stolarova, et al.
Published: (2020-10-01)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
by: Francesco Spagnolo, et al.
Published: (2021-05-01)

Expression of cyclin-dependent kinase inhibitors (CDKN1, CDKN5) in developmentally competent and incompetent porcine oocytes
by: H. Piotrowska, et al.
Published: (2013-09-01)

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center
by: Gabriele Roccuzzo, et al.
Published: (2023-07-01)

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience
by: Joon Young Hur, et al.
Published: (2020-05-01)

Application of Multilayer Evidence for Annotation of C-Terminal <i>BRCA2</i> Variants
by: Henriett Butz, et al.
Published: (2021-02-01)

A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State
by: Ying Liu, et al.
Published: (2015-10-01)

A Rare Case of Primary Anorectal Melanoma and a Review of the Current Landscape of Therapy
by: Ho-Man Yeung, et al.
Published: (2020-07-01)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
by: Miyuki Kitahara, et al.
Published: (2021-11-01)

Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients
by: Bianca Costa Soares de Sá, et al.
Published: (2023-10-01)

Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders
by: Jennie Vagher, et al.
Published: (2022-03-01)

Germline <i>POT1</i> Variants: A Critical Perspective on <i>POT1</i> Tumor Predisposition Syndrome
by: Virginia Andreotti, et al.
Published: (2024-01-01)

A rare case of endobronchial melanoma of unknown primary
by: Beop Chang Kim, et al.
Published: (2023-01-01)

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction
by: Laura Caleca, et al.
Published: (2018-10-01)

Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report
by: Ah-Reum Jeong, et al.
Published: (2022-02-01)

A Rare Case Series of Vaginal Melanoma- experience of National Cancer Institute Sri Lanka
by: YMTY Wijeratne, et al.
Published: (2022-05-01)

Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates NCK1 as a Cancer Gene
by: Jie Yin, et al.
Published: (2019-06-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C
by: Chao Yang, et al.
Published: (2020-01-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

А rare case of primary malignant melanoma of the female urethra
by: G. Raycheva, et al.
Published: (2023-03-01)

Double Heterozygosity for Rare Deleterious Variants in the <i>BRCA1</i> and <i>BRCA2</i> Genes in a Hungarian Patient with Breast Cancer
by: László Madar, et al.
Published: (2023-10-01)